Is FDA Approval Of TAUKLARIFY Alzheimer’s Tau PET Agent Altering The Investment Case For Lantheus (LNTH)?Simplywall·2 days ago, 04:30 AMLNTH+0.10%
232,597 Shares in Lantheus Holdings, Inc. $LNTH Acquired by William Blair Investment Management LLCMarket Beat·Aug 23 at 04:52 AMLNTH+0.10%
Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $106.3, Implies 6% UpsideTradingView·Aug 19 at 03:20 AMLNTH+0.10%
Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approvalPharmaceutical Technology·Aug 17 at 05:47 AMLNTH+0.10%
Lantheus wins FDA approval for TauklariFY Alzheimer’s tau PET imaging agentPUBT·Aug 14 at 07:06 AMLNTH+0.10%
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and morebusinessinsider·Aug 9 at 09:59 AMATKR+0.04%LNTH+0.10%
Lantheus (NASDAQ:LNTH) Releases Earnings Results, Beats Expectations By $0.25 EPSMarket Beat·Aug 7 at 08:41 PMLNTH+0.10%
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?PR Newswire·Aug 7 at 01:16 PMDSGR+0.06%ATKR+0.04%
